BlossomHill Therapeutics to Present the Design and Discovery of BH-30643, the Company’s OMNI-EGFR™ Inhibitor, at the 2025 AACR Annual Meeting
BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...
Bored of Ghibli-style images? You can try Shonen, Cartoon Network, and 26 other art styles ChatGPT can create
ChatGPT can generate images in a variety of styles, ranging from anime and cartoons to realistic and abstract designs. Here’s ...
Business Review1d
Interactive Resumes: Crafting Digital Portfolios with AI for a Job-Winning Edge
Online - It takes more than just a strong LinkedIn profile or conventional CV to stand out in the competitive job market of ...
Waste Dive2d
Hitting a plateau: Circular packaging designers face flexibles hurdle
Many companies have targets to make 100% of their packaging recyclable, reusable or compostable by 2025. Now, as they face ...